Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.200
+0.080 (3.77%)
Jan 29, 2026, 4:00 PM EST - Market closed

Neuronetics Revenue

Neuronetics had revenue of $37.30M in the quarter ending September 30, 2025, with 101.28% growth. This brings the company's revenue in the last twelve months to $129.87M, up 78.62% year-over-year. In the year 2024, Neuronetics had annual revenue of $74.89M with 4.96% growth.

Revenue (ttm)
$129.87M
Revenue Growth
+78.62%
P/S Ratio
0.98
Revenue / Employee
$181,387
Employees
716
Market Cap
150.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202474.89M3.54M4.96%
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 202049.24M-13.41M-21.41%
Dec 31, 201962.66M9.88M18.72%
Dec 31, 201852.78M12.34M30.53%
Dec 31, 201740.43M6.21M18.13%
Dec 31, 201634.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inogen347.03M
Treace Medical Concepts218.88M
InfuSystem Holdings141.05M
AVITA Medical72.40M
LENSAR59.14M
CVRx, Inc.55.97M
Apyx Medical47.90M
Rapid Micro Biosystems30.52M
Revenue Rankings